Hepion Pharmaceuticals, Inc. - 8-K Filing
Hepion Pharmaceuticals acquires GLS for $2.135M cash and 25 million shares; transaction involves related parties (Items: 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 2, 9.01 Financial Statements and Exhibits (d) Exhibits 2)
Tickers: $HEPA